Provided by Tiger Fintech (Singapore) Pte. Ltd.

e.l.f. Beauty Inc.

53.47
+0.82001.56%
Post-market: 53.45-0.0200-0.04%18:17 EDT
Volume:2.29M
Turnover:121.09M
Market Cap:3.02B
PE:31.92
High:53.87
Open:51.65
Low:50.79
Close:52.65
Loading ...

Elf Beauty price target lowered to $64 from $75 at DA Davidson

TIPRANKS
·
02 Apr

elf Beauty Is Maintained at Overweight by Piper Sandler

Dow Jones
·
31 Mar

U.S. RESEARCH ROUNDUP- Braze, Home Bancshares, Union Pacific

Reuters
·
31 Mar

elf Beauty Inc : Piper Sandler Cuts Target Price to $90 From $102

THOMSON REUTERS
·
31 Mar

Garmin and e.l.f. Beauty have been highlighted as Zacks Bull and Bear of the Day

Zacks
·
28 Mar

BUZZ-Jefferies bearish on brick and mortar beauty retailers

Reuters
·
27 Mar

Is e.l.f. Beauty (ELF) an Undervalued Stock to Invest in According to Goldman Sachs?

Insider Monkey
·
22 Mar

HELE vs. ELF: Which Stock Should Value Investors Buy Now?

Zacks
·
19 Mar

Are These 3 Beaten Down Consumer Stocks Worth a Look?

Zacks
·
19 Mar

e.l.f. Beauty (NYSE:ELF) Faces Volatility Amid $500M Credit Facility News

Simply Wall St.
·
19 Mar

Jim Cramer Says You Should Not Sell e.l.f. Beauty (ELF) Shares

Insider Monkey
·
19 Mar

e.l.f. Beauty Needs to Show Better Point of Sale Growth -- Market Talk

Dow Jones
·
18 Mar

elf Beauty Is Maintained at Neutral by DA Davidson

Dow Jones
·
17 Mar

DA Davidson Adjusts Price Target on e.l.f. Beauty to $75 From $80, Keeps Neutral Rating

MT Newswires Live
·
17 Mar

Ulta Beauty tops quarterly results on strong holiday demand for cosmetics, perfumes

Reuters
·
14 Mar

Overstated Revenue Gets Ugly for e.l.f. Beauty

TIPRANKS
·
08 Mar

Why e.l.f. Beauty, Inc. (ELF) is the Best Vegan Stock to Buy According to Analysts

Insider Monkey
·
08 Mar

e.l.f. Beauty (NYSE:ELF) Scores with Women’s Soccer Goals

TIPRANKS
·
07 Mar

e.l.f. Launches Multi-year Sponsorship with National Women’s Soccer League in Ongoing Leveling of the Playing Field

Business Wire
·
07 Mar

New Data Presented at CORA 2025 Conference Highlights Clinical Potential of Chemomab’s Nebokitug in Systemic Sclerosis

GlobeNewswire
·
06 Mar